DOCSLIB.ORG

News Release for Immediate Release Contact: Laurie Fox, Asst

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
News Release for Immediate Release Contact: Laurie Fox, Asst Melissa Howell, MS, MBA, MPH, RN, RS, Health Commissioner Robert P. Dillaplain, MD, Medical Director News Release For Immediate Release Contact: Laurie Fox, Asst. Public Information Officer July 24, 2013 (937) 374-5669 or 1 (866) 858-3588 GCCHD Recognizes World Hepatitis Day, July 28, 2013 XENIA, OHIO -- Every year on July 28, the World Health Organization (WHO) and partners mark World Hepatitis Day to increase the awareness and understanding of viral hepatitis and the diseases that it causes. Hepatitis viruses A, B, C, D and E can cause acute and chronic infection and inflammation of the liver that can lead to cirrhosis and liver cancer. These viruses constitute a major global health risk with around 240 million people being chronically infected with hepatitis B and around 150 million people chronically infected with hepatitis C. For 2013, the overall theme continues to be "This is hepatitis. Know it. Confront it." The campaign emphasizes the fact that hepatitis remains largely unknown as a health threat in much of the world. Millions of people are living with viral hepatitis and millions more are at risk of becoming infected. Most people with chronic infection with hepatitis B or C are unaware that they continue to carry the virus. They are therefore at high risk of developing severe chronic liver disease and can unknowingly transmit the virus to other people. Approximately one million people die each year from causes related to viral hepatitis, most commonly cirrhosis and liver cancer. World Hepatitis Day provides an opportunity to focus on specific actions, such as: • Strengthening prevention, screening and control of viral hepatitis and its related diseases; • Increasing hepatitis B vaccine coverage and integration of the vaccine into national immunization programs; • Coordinating a global response to viral hepatitis. Although the burden of disease related to hepatitis infection is very high, in most countries, the problem has not been addressed in a comprehensive way for many reasons. These include the fact that most people do not develop any symptoms when they become infected and that they remain free of symptoms often for decades until they develop chronic liver disease. This has largely resulted in "the silent epidemic" we are experiencing today. Viral hepatitis also places a heavy burden on the health-care system because of the high costs of treatment of liver cancer and liver failure from cirrhosis. In many countries, liver failure from viral hepatitis is the leading reason for liver transplants. Such end-stage treatments are expensive, easily costing up to hundreds of thousands of dollars per person. (continued) The date of July 28 was chosen for World Hepatitis Day in honor of the birthday of Nobel Laureate Professor Baruch Samuel Blumberg, discoverer of the hepatitis B virus. Hepatitis C is a leading cause of liver cancer and millions of Americans have hepatitis C, but it is estimated that 75% of those infected don’t know it. This is because people can live with hepatitis C for decades without having symptoms or feeling sick. Hepatitis C is found in the blood, but it is not screened for in routine blood work. Getting tested is the only way to know if you are infected. The CDC currently recommends hepatitis C testing for all people born between 1945-1965 as well as anyone who has been exposed to blood either through a needle stick injury, blood transfusion prior to 1992 or sharing injection drug use equipment, even if only one time. Early detection of hepatitis C can save lives and improve treatment outcomes. Free rapid hepatitis C testing is offered at the offices of the GCCHD, 360 Wilson Dr., Xenia on the first and third Wednesday of every month from 1:00 to 3:00pm on a walk-in basis or on other days by appointmen t. For more information regarding hepatitis C testing, please contact HIV Health Educator, Kirsten Bean, at (937) 374-5646 or [email protected] . The GCCHD also holds immunization clinics that offer vaccinations for hepatitis A and B. Walk-ins are accepted. Times and days are listed below: • Every Tuesday: 8:00 - 11:00 a.m. and 12:30 - 3:00 p.m. • Second and Fourth Thursday of every month: 4:00 - 6:00 p.m. FOR MORE INFORMATION on clinics and available services at GCCHD, please call 937-374-5600 or toll free at 1-866-858-3588. You can also visit the website at www.gcchd.org. Greene County Combined Health District – Your center for public health services and information in Greene County for over 90 years. Healthy People…Healthy Communities 360 Wilson Drive Xenia, OH 45385 937-374-5600 * 866-858-3588 * Fax 937-374-5675 www.gcchd.org ### .
Load more

Recommended publications
  • 書 名 等 発行年 出版社 受賞年 備考 N1 Ueber Das Zustandekommen Der
    書 名 等 発行年 出版社 受賞年 備考 Ueber das Zustandekommen der Diphtherie-immunitat und der Tetanus-Immunitat bei thieren / Emil Adolf N1 1890 Georg thieme 1901 von Behring N2 Diphtherie und tetanus immunitaet / Emil Adolf von Behring und Kitasato 19-- [Akitomo Matsuki] 1901 Malarial fever its cause, prevention and treatment containing full details for the use of travellers, University press of N3 1902 1902 sportsmen, soldiers, and residents in malarious places / by Ronald Ross liverpool Ueber die Anwendung von concentrirten chemischen Lichtstrahlen in der Medicin / von Prof. Dr. Niels N4 1899 F.C.W.Vogel 1903 Ryberg Finsen Mit 4 Abbildungen und 2 Tafeln Twenty-five years of objective study of the higher nervous activity (behaviour) of animals / Ivan N5 Petrovitch Pavlov ; translated and edited by W. Horsley Gantt ; with the collaboration of G. Volborth ; and c1928 International Publishing 1904 an introduction by Walter B. Cannon Conditioned reflexes : an investigation of the physiological activity of the cerebral cortex / by Ivan Oxford University N6 1927 1904 Petrovitch Pavlov ; translated and edited by G.V. Anrep Press N7 Die Ätiologie und die Bekämpfung der Tuberkulose / Robert Koch ; eingeleitet von M. Kirchner 1912 J.A.Barth 1905 N8 Neue Darstellung vom histologischen Bau des Centralnervensystems / von Santiago Ramón y Cajal 1893 Veit 1906 Traité des fiévres palustres : avec la description des microbes du paludisme / par Charles Louis Alphonse N9 1884 Octave Doin 1907 Laveran N10 Embryologie des Scorpions / von Ilya Ilyich Mechnikov 1870 Wilhelm Engelmann 1908 Immunität bei Infektionskrankheiten / Ilya Ilyich Mechnikov ; einzig autorisierte übersetzung von Julius N11 1902 Gustav Fischer 1908 Meyer Die experimentelle Chemotherapie der Spirillosen : Syphilis, Rückfallfieber, Hühnerspirillose, Frambösie / N12 1910 J.Springer 1908 von Paul Ehrlich und S.
    [Show full text]
  • Simulating Physics with Computers
    International Journal of Theoretical Physics, VoL 21, Nos. 6/7, 1982 Simulating Physics with Computers Richard P. Feynman Department of Physics, California Institute of Technology, Pasadena, California 91107 Received May 7, 1981 1. INTRODUCTION On the program it says this is a keynote speech--and I don't know what a keynote speech is. I do not intend in any way to suggest what should be in this meeting as a keynote of the subjects or anything like that. I have my own things to say and to talk about and there's no implication that anybody needs to talk about the same thing or anything like it. So what I want to talk about is what Mike Dertouzos suggested that nobody would talk about. I want to talk about the problem of simulating physics with computers and I mean that in a specific way which I am going to explain. The reason for doing this is something that I learned about from Ed Fredkin, and my entire interest in the subject has been inspired by him. It has to do with learning something about the possibilities of computers, and also something about possibilities in physics. If we suppose that we know all the physical laws perfectly, of course we don't have to pay any attention to computers. It's interesting anyway to entertain oneself with the idea that we've got something to learn about physical laws; and if I take a relaxed view here (after all I'm here and not at home) I'll admit that we don't understand everything.
    [Show full text]
  • Race in the Age of Obama Making America More Competitive
    american academy of arts & sciences summer 2011 www.amacad.org Bulletin vol. lxiv, no. 4 Race in the Age of Obama Gerald Early, Jeffrey B. Ferguson, Korina Jocson, and David A. Hollinger Making America More Competitive, Innovative, and Healthy Harvey V. Fineberg, Cherry A. Murray, and Charles M. Vest ALSO: Social Science and the Alternative Energy Future Philanthropy in Public Education Commission on the Humanities and Social Sciences Reflections: John Lithgow Breaking the Code Around the Country Upcoming Events Induction Weekend–Cambridge September 30– Welcome Reception for New Members October 1–Induction Ceremony October 2– Symposium: American Institutions and a Civil Society Partial List of Speakers: David Souter (Supreme Court of the United States), Maj. Gen. Gregg Martin (United States Army War College), and David M. Kennedy (Stanford University) OCTOBER NOVEMBER 25th 12th Stated Meeting–Stanford Stated Meeting–Chicago in collaboration with the Chicago Humanities Perspectives on the Future of Nuclear Power Festival after Fukushima WikiLeaks and the First Amendment Introduction: Scott D. Sagan (Stanford Introduction: John A. Katzenellenbogen University) (University of Illinois at Urbana-Champaign) Speakers: Wael Al Assad (League of Arab Speakers: Geoffrey R. Stone (University of States) and Jayantha Dhanapala (Pugwash Chicago Law School), Richard A. Posner (U.S. Conferences on Science and World Affairs) Court of Appeals for the Seventh Circuit), 27th Judith Miller (formerly of The New York Times), Stated Meeting–Berkeley and Gabriel Schoenfeld (Hudson Institute; Healing the Troubled American Economy Witherspoon Institute) Introduction: Robert J. Birgeneau (Univer- DECEMBER sity of California, Berkeley) 7th Speakers: Christina Romer (University of Stated Meeting–Stanford California, Berkeley) and David H.
    [Show full text]
  • Baruch S. Blumberg 1925–2011
    Baruch S. Blumberg 1925–2011 A Biographical Memoir by W. Thomas London ©2014 National Academy of Sciences. Any opinions expressed in this memoir are those of the author and do not necessarily reflect the views of the National Academy of Sciences. BARUCH SAMUEL BLUMBERG July 28, 1925–April 5, 2011 Elected to the NAS, 1975 Baruch S. Blumberg was a research scientist who received the Nobel Prize for Physiology or Medicine for his discovery of the Australia antigen, one of the most important advances in the field of Hepatology. Known to everyone as Barry, he was an unlikely person to have made the discoveries that had such a huge impact on public health, liver disease, infectious disease and virology. Barry was not a virologist, a hepatologist, an infectious disease specialist, or an epidemiologist. He had minimal clin- ical training in medicine and no formal training in those other disciplines. He was, in fact, more of a 19th century natural scientist than a 20th century laboratory or clin- ical scientist. Finding the cause of viral hepatitis was not what he had in mind when he began his research career. By W. Thomas London Yet Barry’s discovery, made with teams in Philadelphia and Bethesda, led to the virtual elimination of transfusion-related hepatitis B in most parts of the world, and was essential to the identification of hepatitis A, C, D, and E viruses. When he identified the Australia antigen as the outer coat of the previously unidentified hepatitis B virus, it was the prelude to the invention of the first vaccine to prevent infection with the virus, the demonstration of its association with acute and chronic hepatitis B, cirrhosis, and liver cancer, and ultimately the prevention of liver cancer.
    [Show full text]
  • Prehľad Dejín Biológie, Lekárstva a Farmácie
    VYSOKOŠKOLSKÁ UČEBNICA UNIVERZITA PAVLA JOZEFA ŠAFÁRIKA V KOŠICIACH PRÍRODOVEDECKÁ FAKULTA Katedra botaniky Prehľad dejín biológie, lekárstva a farmácie Martin Bačkor a Miriam Bačkorová Košice 2018 PREHĽAD DEJÍN BIOLÓGIE, LEKÁRSTVA A FARMÁCIE Vysokoškolská učebica Prírodovedeckej fakulty UPJŠ v Košiciach Autori: 2018 © prof. RNDr. Martin Bačkor, DrSc. Katedra botaniky, Prírodovedecká fakulta, UPJŠ v Košiciach 2018 © RNDr. Miriam Bačkorová, PhD. Katedra farmakognózie a botaniky, UVLF v Košiciach Recenzenti: doc. RNDr. Roman Alberty, CSc. Katedra biológie a ekológie, Fakulta prírodných vied, UMB v Banskej Bystrici doc. MVDr. Tatiana Kimáková. PhD. Ústav verejného zdravotníctva, Lekárska fakulta, UPJŠ v Košiciach Vedecký redaktor: prof. RNDr. Beňadik Šmajda, CSc. Katedra fyziológie živočíchov, Prírodovedecká fakulta, UPJŠ v Košiciach Technický editor: Mgr. Margaréta Marcinčinová Všetky práva vyhradené. Toto dielo ani jeho žiadnu časť nemožno reprodukovať, ukladať do in- formačných systémov alebo inak rozširovať bez súhlasu majiteľov práv. Za odbornú a jazykovú stránku tejto publikácie zodpovedajú autori. Rukopis neprešiel redakčnou ani jazykovou úpravou Tento text vznikol aj vďaka materiálnej pomoci z projektu KEGA 012UPJŠ-4/2016. Vydavateľ: Univerzita Pavla Jozefa Šafárika v Košiciach Dostupné od: 22. 10. 2018 ISBN 978-80-8152-650-3 OBSAH PREDHOVOR ................................................. 5 1 STAROVEK ................................................ 6 1.1 Zrod civilizácie ........................................................8
    [Show full text]
  • Bangladesh Journal (Vol. 3, No. 1) Book (01-03-2016)
    Volume 3 Naumber 1 March 2016 ISSN 2071-2324 BANGLADESH Jounrnal of HEPATOLOGY Official Journal of ASSOCIATION FOR THE STUDY OF LIVER Association for the Study of Liver Diseases Bangladesh DISEASES BANGLADESH (National Association of Hepatologists of Bangladesh) Bangladesh Journal of Hepatology Bangladesh Journal of Hepatology Official Journal of Association for the Study of Liver Diseases Bangladesh (National body of Hepatologists of Bangladesh) Correspondence Room # 506, 4th floor Block # D Bangabandhu Sheikh Mujib Medical University Shahbag, Dhaka-1000 Email: [email protected], [email protected] Vol. 3 No. 1 01 Bangladesh Journal of Hepatology Bangladesh Journal of Hepatology Editorial Board Editor in Chief Professor Salimur Rahman Associate Editor Dr. Ayub Al Mamun Dr. Chitto Ranjan Debnath Dr. Faroque Ahmed Dr. K. M. J. Zaki Dr. Mamun-Al-Mahtab Dr. Md. Jasmshed Alam Khan Assistant Editor Dr. Harun Or Rashid Dr. Md. Fazal Karim Dr. Md. Izazul Haque Dr. Muhammad Mahbub Hossain Editorial Board Dr. Abu Saleh Md. Sadequl Islam Dr. Abul Barkat Muhammad Adnan Dr. Ahmed Lutful Moben Dr. Amalendu Bhattacharyya Dr. Arun Jyoti Tarafder Dr. Forhad Hossain Md. Shahed Dr. Golam Mashud Dr. Kutub Uddin Mollick Dr. Md. Abdur Rahim Dr. Md. Ashraful Alam Dr. Md. Dalil Uddin Dr. Md. Jahangir Alam Sarker Dr. Md. Zia Hayder Bosunia Dr. Mohammad Faiz Ahmad Khondaker Dr. Provat Kumar Podder Dr. Shamsul Kabir Dr. Sheikh Mohammad Noor-E-Alam Dr. Syed Abul Foez 02 Vol. 3 No. 1 Bangladesh Journal of Hepatology Volume 3 Number 1 Content Editorial Page Bangladesh
    [Show full text]
  • Contributions of Civilizations to International Prizes
    CONTRIBUTIONS OF CIVILIZATIONS TO INTERNATIONAL PRIZES Split of Nobel prizes and Fields medals by civilization : PHYSICS .......................................................................................................................................................................... 1 CHEMISTRY .................................................................................................................................................................... 2 PHYSIOLOGY / MEDECINE .............................................................................................................................................. 3 LITERATURE ................................................................................................................................................................... 4 ECONOMY ...................................................................................................................................................................... 5 MATHEMATICS (Fields) .................................................................................................................................................. 5 PHYSICS Occidental / Judeo-christian (198) Alekseï Abrikossov / Zhores Alferov / Hannes Alfvén / Eric Allin Cornell / Luis Walter Alvarez / Carl David Anderson / Philip Warren Anderson / EdWard Victor Appleton / ArthUr Ashkin / John Bardeen / Barry C. Barish / Nikolay Basov / Henri BecqUerel / Johannes Georg Bednorz / Hans Bethe / Gerd Binnig / Patrick Blackett / Felix Bloch / Nicolaas Bloembergen
    [Show full text]
  • Ssfaoggi 201306
    SOCIETA’ DI SCIENZE FARMACOLOGICHE APPLICATE SOCIETY FOR APPLIED PHARMACOLOGICAL SSFAoggi SCIENCES Notiziario di Medicina Farmaceutica Giugno 2013 Bimestrale della Società di Scienze Farmacologiche Applicate Fondata nel 1964 numero 37 Dove sono i nuovi antibiotici? Sommario: La comunità mondiale sta correndo un grosso rischio: questo ci ricordano due editoriali, Editoriale 1 pubblicati su The Lancet e sul British Medical Journal, che riportiamo alle pagine 21 e 22. La resistenza agli antibiotici è un grave problema: The Lancet ci ricorda che fu addirittura Novità in Farmacovigilanza messa in evidenza dallo stesso Alexander Fleming nel 1945, il quale temeva che l’abuso Parte prima 2 della penicillina potesse selezionare ceppi resistenti. Il British Medical Journal evidenzia che molte pratiche mediche e chirurgiche (dall’uso Novità in Farmacovigilanza della chemioterapia agli interventi invasivi in ortopedia e cardiochirurgia) sono possibili Parte seconda 4 grazie alla profilassi con antibiotici. E quindi, la resistenza agli antibiotici non è un solo un problema degli infettivologi, ma sta diventando un problema dei chirurghi, degli oncologi, e Il Decreto Balduzzi 6 di tutto il sistema sanitario. Alcune previsioni sono drammatiche: l’intervento di protesi dell’anca, che è diventato una Farmaci a brevetto scaduto 12 routine per la popolazione anziana, potrebbe essere colpito in modo significativo da com- plicanze infettive, passando dall’1% dei pazienti di oggi fino al 40%-50% dei pazienti nel Affari Istituzionali 12 prossimo futuro, con oltre un terzo di essi in pericolo di vita. Uno scenario davvero preoc- 5a Edizione Master Bicocca 13 cupante. Di fronte a queste previsioni, che ci vengono ormai ripetute ad intervalli regolari, stupisce Master Bicocca 2013: i numeri 13 la mancanza di incentivi per la ricerca di nuovi antibiotici.
    [Show full text]
  • Laureatai Pagal Atradimų Sritis
    1 Nobelio premijų laureatai pagal atradimų sritis Toliau šioje knygoje Nobelio fiziologijos ir medicinos premijos laureatai suskirstyti pagal jų atradimus tam tikrose fiziologijos ir medicinos srityse. Vienas laureatas gali būti įrašytas keliose srityse. Akies fiziologija 1911 m. Švedų oftalmologas Allvar Gullstrand – už akies lęšiuko laužiamosios gebos tyrimus. 1967 m. Suomių ir švedų neurofiziologas Ragnar Arthur Granit, amerikiečių fiziologai Haldan Keffer Hartline ir George Wald – už akyse vykstančių pirminių fiziologinių ir cheminių procesų atradimą. Antibakteriniai vaistai 1945 m. Škotų mikrobiologas seras Alexander Fleming, anglų biochemikas Ernst Boris Chain ir australų fiziologas seras Howard Walter Florey – už penicilino atradimą ir jo veiksmingumo gydant įvairias infekcijas tyrimus. 1952 m. Amerikiečių mikrobiologas Selman Abraham Waksman – už streptomicino, pirmojo efektyvaus antibiotiko nuo tuberkuliozės, sukūrimą. Audiologija 1961 m. Vengrų biofizikas Georg von Békésy – už sraigės fizinio dirginimo mechanizmo atradimą. Bakteriologija 1901 m. Vokiečių fiziologas Emil Adolf von Behring – už serumų terapijos darbus, ypač pritaikius juos difterijai gydyti (difterijos antitoksino sukūrimą). 1905 m. Vokiečių bakteriologas Heinrich Hermann Robert Koch – už tuberkuliozės tyrimus ir atradimus. 1928 m. Prancūzų bakteriologas Charles Jules Henri Nicolle – už šiltinės tyrimus. 1939 m. Vokiečių bakteriologas Gerhard Johannes Paul Domagk – už prontozilio antibakterinio veikimo atradimą. 1945 m. Škotų mikrobiologas Alexander Fleming, anglų biochemikas Ernst Boris Chain ir australų fiziologas Howard Walter Florey – už penicilino atradimą ir jo veiksmingumo gydant įvairias infekcijas tyrimus. 1952 m. Amerikiečių mikrobiologas Selman Abraham Waksman – už streptomicino, pirmojo efektyvaus antibiotiko nuo tuberkuliozės, sukūrimą. 2005 m. 2 Australų mikrobiologas Barry James Marshall ir australų patologas John Robin Warren – už bakterijos Helicobacter pylori atradimą ir jos įtakos skrandžio ir dvylikapirštės žarnos opos atsivėrimui nustatymą.
    [Show full text]
  • ASP NEWSLETTER VOLUME 51, ISSUE 4 PAGE 2 Ōmura: 2015 Nobel Laureate in Medicine Memoriam: David J
    The American Society Discovering Nature’s of Molecular Potential PharmacognosyThe ASP Newsletter: Volume 51, Issue 4 ASP Fellow Ōmura In Memoriam Awarded Nobel Prize David J. Slatkin By Drs. James B. McAlpine and David J. Newman By Drs. Paul L. Schiff Jr., Melany Puglisi-Weening, and John H. Cardellina II r. Satoshi Ōmura was one of three n November 16, 2015 Nobel Prize 2015, David Joseph winners in Physiol- Slatkin, PhD, for- Dogy or Medicine. The ASP mer Treasurer and was “ahead of the game,” Olongtime Honorary Member as he was the Norman of the ASP, passed away R. Farnsworth awardee after a long battle with Par- at the 2013 ASP Annual kinson’s disease. Many ASP Meeting for his superb members are likely to think work in antibiotics and of David as the long time related compounds; he ASP Treasurer who was a also became an ASP Fel- driving force in growing the Drs. McAlpine and Ōmura. low as a result of this Society’s financial holdings, award by the Society. It is propitious that ASP recognized his stature but Professor Slatkin was Dr. David Slatkin before the award of the Nobel Prize for Medicine this year for his also one of the country’s work on the avermectin/ivermectin class of microbial metabolites, most influential pharma- sharing the award with Dr. William Campbell, originally from Merck cists, spending most of his career making tremendous Sharp and Dohme, (one half the award to these two gentlemen) and contributions to pharmocognosy and pharmacy education. the other half to Dr. Tu Youyou for her work on artemisinin.
    [Show full text]
  • ¿Hasta Cuándo?
    ANALES MEDICOS Volumen Número Abril-Junio Volume 50 Number 2 April-June 2005 Artículo: Editorial. ¿Hasta cuándo? Derechos reservados, Copyright © 2005: Asociación Médica del American British Cowdray Hospital, AC Otras secciones de Others sections in este sitio: this web site: ☞ Índice de este número ☞ Contents of this number ☞ Más revistas ☞ More journals ☞ Búsqueda ☞ Search edigraphic.com ANALES Editorial MEDICOS HOSPITAL ABC Vol. 50, Núm. 2 Abr. - Jun. 2005 pp. 56 - 57 ¿Hasta cuándo? Guillermo A. Rojas Reyna Entenderemos que el tabaquismo es una pande- tal manera que siete de cada 10 personas estamos mia que va en aumento, que ocasiona serios pro- expuestas en mayor o menor grado a los efectos blemas de salud y elevadas tasas de mortalidad. dañinos del tabaco. Al respecto, se ha observado Actualmente, la mortalidad mundial por enfer- que la mortalidad de esposas no fumadoras que medades asociadas al tabaco es de 4 millones de conviven con maridos fumadores de una cajetilla personas por año, 8,242 por día y una cada ocho diaria, es casi dos veces más que la de esposas de segundos. Se calcula que para el año 2020 serán no fumadores; pero si ambos fuman hasta 20 ci- 10 millones de decesos anuales y uno cada tres garrillos cada uno por día, la mortalidad aumenta segundos. cuatro veces y si los dos consumen más de una En México, los fallecimientos relacionados a los cajetilla diaria cada uno, ésta se incrementará efectos nocivos del tabaquismo son 53,000 por año, hasta seis veces. No quiero imaginarme cuál es el 4,410 al mes, 1,029 por semana, 147 por día y seis pronóstico de salud y vida de los hijos que naz- cada hora.
    [Show full text]
  • Redalyc.Día Mundial De Las Hepatitis Virales: Una Buena Excusa Para
    Química Viva E-ISSN: 1666-7948 [email protected] Universidad de Buenos Aires Argentina Oubiña, José Raúl Día mundial de las hepatitis virales: una buena excusa para honrar a un pro-hombre y para reflexionar ... Química Viva, vol. 12, núm. 3, -diciembre, 2013, pp. 167-177 Universidad de Buenos Aires Buenos Aires, Argentina Disponible en: http://www.redalyc.org/articulo.oa?id=86329278002 Cómo citar el artículo Número completo Sistema de Información Científica Más información del artículo Red de Revistas Científicas de América Latina, el Caribe, España y Portugal Página de la revista en redalyc.org Proyecto académico sin fines de lucro, desarrollado bajo la iniciativa de acceso abierto Revista QuímicaViva - Número 3, año 12, diciembre 2013 - [email protected] Día mundial de las hepatitis virales: una buena excusa para honrar a un pro-hombre y para reflexionar … José Raúl Oubiña Prof Regular Titular del Depto. Microbiología, Parasitología e Inmunología Facultad de Medicina - UBA Investigador Principal del Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) Instituto de Microbiología y Parasitología Médica (IMPaM) UBA - CONICET ¿Por qué se eligió al 28 de julio? El 28 de julio fue instituido en 2010 por la Asamblea Mundial de la Salud como el "Día Mundial de las Hepatitis virales" en homenaje al cumpleaños del descubridor del agente etiológico de la hepatitis B, el Prof. Baruch Samuel Blumberg, Premio Nobel de Medicina o Fisiología de 1976 (Fig. 1). Figura 1: "Barry" Blumberg, un investigador que supo ensamblar un rompecabezas de datos epidemiológicos aparentemente inconexos estudiando una "inusual" reacción entre el suero de individuos politransfundidos (por ejemplo, leucémicos) y el de un aborigen australiano.
    [Show full text]